Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma (Q34571278)

3 August 2017

Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma (English)

1 reference

3 August 2017

0 references

3

Francesco Vitale

1 reference

3 August 2017

12

James J Goedert

1 reference

3 August 2017

Elizabeth E Brown

1

1 reference

3 August 2017

Denise Whitby

2

1 reference

3 August 2017

Vickie Marshall

4

1 reference

3 August 2017

Georgina Mbisa

5

1 reference

3 August 2017

Christine Gamache

6

1 reference

3 August 2017

Carmela Lauria

7

1 reference

3 August 2017

Anthony J Alberg

8

1 reference

3 August 2017

Diego Serraino

9

1 reference

3 August 2017

Paola Cordiali-Fei

10

1 reference

3 August 2017

Angelo Messina

11

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

3 August 2017

1 reference

3 August 2017

107

1 reference

3 August 2017

9

1 reference

3 August 2017

2282-2290

1 reference

Kaposi's sarcoma pathogenesis: a link between immunology and tumor biology

3 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

Risk factors for classical Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

The role of immunosuppression and immune-activation in classic Kaposi's sarcoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

Association of clinical progression in classic Kaposi's sarcoma with reduction of peripheral B lymphocytes and partial increase in serum immune activation markers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

Endemic African Kaposi's sarcoma is not associated with immunodeficiency

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

Urinary neopterin and immunological features in patients with Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

A quantification of human cells using an ERV-3 real time PCR assay

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

Frequency and distribution of herpesvirus-like DNA sequences (KSHV) in different stages of classic Kaposi's sarcoma and in normal tissues from an Italian population

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

Human Herpesvirus 8 in Italian HIV-Seronegative Patients With Kaposi Sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

Kaposi's sarcoma in renal transplant recipients. Ultrastructural and immunoperoxidase study of four cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

Kaposi's sarcoma: a reversible hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

Immunologic and immunogenetic features of primary Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

Associations of Classic Kaposi Sarcoma with Common Variants in Genes that Modulate Host Immunity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

Host Immunogenetics and Control of Human Herpesvirus–8 Infection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22236

7 January 2021

Identifiers

DOI

10.1002/CNCR.22236

1 reference

3 August 2017

1 reference